- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8533
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,533 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RMDA | ج.م2.57 | 2.4% | 73.9% | ج.م3.9b | ج.م4.38 | PE17x | E30.3% | 2.6% | Pharmaceuticals & Biotech | ||
FWRY | ج.م7.64 | 2.8% | 37.7% | ج.م26.0b | ج.م10.92 | PE27x | E31.0% | n/a | Diversified Financials | ||
AXSM | US$93.67 | -0.4% | 25.6% | US$4.5b | US$125.24 | PS15.4x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
CALTX | SEK 206.20 | -0.7% | 121.4% | SEK 11.1b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$28.51 | 17.5% | 89.7% | US$4.7b | US$35.33 | PS21.8x | E94.1% | n/a | Semiconductors | ||
AOT | CA$0.17 | -2.9% | -64.1% | CA$116.6m | n/a | PS48.2x | E46.9% | n/a | Materials | ||
MVW | NOK 11.00 | -2.7% | 35.1% | NOK 359.9m | NOK 12.20 | PS20.9x | E71.6% | n/a | Materials | ||
GTHX | US$7.15 | 0.1% | 379.9% | US$378.2m | US$7.15 | PS6.5x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
SCOL | SEK 0.13 | -14.0% | -92.2% | SEK 29.9m | n/a | PB0.6x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
RHM | €521.00 | 2.8% | 96.6% | €22.6b | €616.44 | PE34.7x | E27.7% | 1.1% | Capital Goods | ||
CADLR | NOK 70.50 | 5.7% | 87.1% | NOK 24.7b | NOK 81.94 | PS17x | E67.8% | n/a | Capital Goods | ||
NEWBRY | SEK 3.26 | 5.2% | -16.6% | SEK 79.1m | SEK 8.00 | PS4.3x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
AGP | €6.58 | 1.5% | 65.7% | €113.9m | €12.75 | PE23.2x | E22.8% | n/a | Capital Goods | ||
KEBNI B | SEK 1.20 | -1.5% | 1.0% | SEK 325.4m | SEK 2.20 | PS2.8x | E86.1% | n/a | Tech | ||
EH | US$12.15 | 4.1% | -29.4% | US$768.9m | US$24.76 | PS21.9x | E81.5% | n/a | Capital Goods | ||
SRPT | US$124.65 | -2.4% | 5.6% | US$11.9b | US$194.36 | PE251.3x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$2.06 | 16.4% | 136.8% | CA$529.3m | CA$3.30 | PE40.1x | E31.2% | n/a | Materials | ||
MBTN | CHF 1.32 | -26.1% | -99.5% | CHF 40.7m | CHF 6.03 | PB0.2x | E95.4% | n/a | Semiconductors | ||
ZVRA | US$7.85 | 8.6% | 54.2% | US$413.0m | US$18.00 | PS17.4x | E69.4% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$13.48 | 4.8% | 0.5% | US$1.0b | US$17.60 | PS5.8x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$23.73 | -0.08% | 149.5% | US$3.4b | US$33.75 | PE35.6x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
GGP | UK£0.055 | -21.4% | -25.2% | UK£277.9m | n/a | PB5.6x | E48.8% | n/a | Materials | ||
ASND | US$119.22 | 2.0% | 16.8% | US$6.8b | US$182.64 | PS19.4x | E68.4% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$20.64 | 3.8% | -10.5% | US$2.3b | US$26.00 | PE15.5x | E42.1% | 4.5% | Energy |